Shanghai Fosun Pharmaceutical (02196): The registration application for Injection of Dexmedetomidine Tartrate has been approved.
Fosun Pharma (02196) announces that its subsidiary, Jinzhou Aohong Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the registration application of metaraminol bitartrate injection. The approved indications include the recovery of blood pressure in cases of acute hypotension, as well as the use in the auxiliary treatment of cardiac arrest and the maintenance of blood pressure after resuscitation following cardiac arrest. In cases of shock caused by inadequate blood volume, this product can be used as an auxiliary treatment to replenish blood volume in emergency situations, in order to restore blood pressure, temporarily maintain cerebral and coronary artery perfusion, until the effect of blood volume replenishment therapy occurs.
Shanghai Fosun Pharmaceutical (02196) announced that its subsidiary Jinzhou Aohong Pharmaceutical Co., Ltd., a holding company of Shanghai Fosun Pharmaceutical Group, has obtained approval from the National Medical Products Administration for the registration of metaraminol bitartrate injection. The approved indications include the restoration of blood pressure in cases of acute hypotension, as well as the adjunct treatment of cardiac arrest and maintenance of blood pressure after resuscitation from cardiac arrest. This product can also be used as adjunct therapy in cases of shock caused by insufficient blood volume to supplement blood volume during emergency situations to raise blood pressure and temporarily maintain brain and coronary artery perfusion until the effects of volume replacement therapy take place.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
